Compile Data Set for Download or QSAR
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 13497
TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799464BDBM799464(US12583841, Compound 10)
Affinity DataIC50: 17nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799457BDBM799457(US12583841, Compound 7)
Affinity DataIC50: 24nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799448BDBM799448(US12583841, Compound 1)
Affinity DataIC50: 25nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799471BDBM799471(US12583841, Compound 14)
Affinity DataIC50: 30nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799465BDBM799465(US12583841, Compound 11)
Affinity DataIC50: 33nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799462BDBM799462(US12583841, Compound 9)
Affinity DataIC50: 42nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799459BDBM799459(US12583841, Compound 8)
Affinity DataIC50: 42nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799469BDBM799469(US12583841, Compound 13)
Affinity DataIC50: 60nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799450BDBM799450(US12583841, Compound 4)
Affinity DataIC50: 64nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799449BDBM799449(US12583841, Compound 2)
Affinity DataIC50: 72nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799468BDBM799468(US12583841, Compound 12)
Affinity DataIC50: 81nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799451BDBM799451(US12583841, Compound 5)
Affinity DataIC50: 96nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799455BDBM799455(US12583841, Compound 6)
Affinity DataIC50: 299nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799451BDBM799451(US12583841, Compound 5)
Affinity DataIC50: 337nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799450BDBM799450(US12583841, Compound 4)
Affinity DataIC50: 462nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799464BDBM799464(US12583841, Compound 10)
Affinity DataIC50: 710nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799457BDBM799457(US12583841, Compound 7)
Affinity DataIC50: 877nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799471BDBM799471(US12583841, Compound 14)
Affinity DataIC50: 1.04E+3nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799468BDBM799468(US12583841, Compound 12)
Affinity DataIC50: 1.28E+3nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799455BDBM799455(US12583841, Compound 6)
Affinity DataIC50: 1.42E+3nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799459BDBM799459(US12583841, Compound 8)
Affinity DataIC50: 1.79E+3nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799469BDBM799469(US12583841, Compound 13)
Affinity DataIC50: 2.44E+3nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799462BDBM799462(US12583841, Compound 9)
Affinity DataIC50: 3.17E+3nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799465BDBM799465(US12583841, Compound 11)
Affinity DataIC50: 3.60E+3nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799449BDBM799449(US12583841, Compound 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Breakthrough Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 799448BDBM799448(US12583841, Compound 1)
Affinity DataIC50: 1.00E+4nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent